Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFH guide en español

This article was originally published in The Tan Sheet

Executive Summary

Council on Family Health, in partnership with FDA, National Consumers League, introduces new Spanish-language guide to educate Latino community on drug interactions. Pamphlet explains different types of interactions, stresses importance of reading labels and warning information. Guide also contains chart of drug interaction warnings for common OTCs. Brochure is available by mail from CFH and on their web site at 1www.cfhinfo.org...

Council on Family Health, in partnership with FDA, National Consumers League, introduces new Spanish-language guide to educate Latino community on drug interactions. Pamphlet explains different types of interactions, stresses importance of reading labels and warning information. Guide also contains chart of drug interaction warnings for common OTCs. Brochure is available by mail from CFH and on their web site at 1 www.cfhinfo.org....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel